Group 1 - The core viewpoint of the article highlights the performance of the Shanghai Composite Index and the Hang Seng Index, with the former declining by 0.37% to close at 3559.95 points and the latter dropping by 1.07% to 24507.81 points [1] - Fudan Zhangjiang's A/H share premium reached 182.7%, ranking fourth among A/H shares, with A-shares closing at 10.83 yuan (up 0.19%) and H-shares at 4.17 HKD (up 1.96%) [1] - Fudan Zhangjiang Biopharmaceutical Co., Ltd. was established in November 1996 in the Zhangjiang Hi-Tech Park, Shanghai, with notable shareholders including Shanghai Pharmaceuticals Holding Co., Ltd. [1] Group 2 - The company focuses on innovative research, development, production, and sales in the biopharmaceutical sector, aiming to become a knowledge-based innovation enterprise [1] - Fudan Zhangjiang has developed competitive advantages in areas such as gene technology drugs, photodynamic therapy drugs, nanotechnology drugs, and oral solid dosage technology drugs, with new products expected to be launched in the market [1] - The company has undertaken several national key science and technology projects, including the "National Key Technology R&D Program," "National High Technology Research and Development Program (863 Program)," and "Major New Drug Creation" projects [1]

前十大AH股偏离值排行 | 股票名称 | H股(港元) | A股 | 溢价率 | 偏离值↓ | | --- | --- | --- | --- | --- | | 安德利果汁(02218) | 19.660 | 51.81 | 215.67% | 37.63% | | 金力永磁(06680) | 18.400 | 27.36 | 78.10% | 22.60% | | 农业银行(01288) | 5.150 | 6.3 | 46.60% | 13.83% | | 康希诺生物(06185) | 44.800 | 80.46 | 115.11% | 11.56% | | 昭衍新药(06127) | 23.950 | 32.34 | 61.75% | 11.02% | | 北京北辰实业股份 (00588) | 0.870 | 1.78 | 144.83% | 10.74% | | 复旦张江(01349) | 4.090 | 10.86 | 218.09% | 10.71% | | 山东墨龙(00568) | 4.410 | 6.36 | 72.79% | 9.57% | | --- | --- | --- | -- ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示概不因本公告全部或任何部份 內容而產生或因依賴該等內容而引致的任何損失承擔任何責任。 二零二五年七月三十日 趙大君 主席 - 1 - 於本公告刊發日期，董事會包括以下人士： 趙大君先生（執行董事） 中國·上海 董事會會議通告 上海復旦張江生物醫藥股份有限公司（「本公司」）之董事會（「董事會」）謹 此公佈，將於二零二五年八月十二日（星期二）舉行董事會會議，以審議及通過 （其中包括）本公司及其附屬公司截至二零二五年六月三十日止六個月之未經審核 中期業績及考慮宣派中期股息（如有）。 承董事會命 薛 燕女士（執行董事） 沈 波先生（非執行董事） 余曉陽女士（非執行董事） 王宏廣先生（獨立非執行董事） 林兆榮先生（獨立非執行董事） 徐培龍先生（獨立非執行董事） * 僅供識別 - 2 - ...

智通财经APP获悉，截止7月30日收盘，东北电气(00042)、弘业期货(03678)、复旦张江(01349)分列AH 溢价率前三位，溢价率分别为743.75%、227.43%、209.05%；宁德时代(03750)、恒瑞医药(01276)、招 商银行(03968)分列AH溢价率末三位，溢价率分别为-20.05%、-3.78%、2.23%。其中安德利果汁 (02218)、金力永磁(06680)、钧达股份(02865)的偏离值位居前三，分别为22.99%、20.11%、17.87%；另 外，东北电气(00042)、中州证券(01375)、国联民生(01456)的偏离值位居后三，分别 为-187.10%、-46.82%、-39.59%。 前十大AH股溢价率排行 前十大AH股偏离值排行 | 股票名称 | H股(港元) | A股 | 溢价率↓ | 偏离值 | | --- | --- | --- | --- | --- | | 东北电气(00042) | 0.320 | 2.25 | 743.75% | -187.10% | | 弘业期货(03678) | 4.520 | 12.36 | 227.43% | -1.00 ...

金融界消息 截至2025年7月29日收盘，复旦张江（688505）报收于10.75元，上涨2.97%，换手率 3.63%，成交量25.78万手，成交金额2.74亿元。 资金流向方面，今日主力资金净流入2811.73万元，占比成交额10.24%。其中，超大单净流入1676.64万 元、占成交额6.11%，大单净流入1135.08万元、占成交额4.14%，中单净流出流出435.29万元、占成交 额1.59%，小单净流出2376.43万元、占成交额8.66%。 天眼查商业履历信息显示，上海复旦张江生物医药股份有限公司，成立于1996年，位于上海市，是一家 以从事专业技术服务业为主的企业。企业注册资本10365.721万人民币，实缴资本10365.721万人民币。 公司法定代表人为赵大君。 通过天眼查大数据分析，上海复旦张江生物医药股份有限公司共对外投资了8家企业，参与招投标项目 270次，知识产权方面有商标信息44条，专利信息184条，此外企业还拥有行政许可78个。 来源：金融界 复旦张江最新一期业绩显示，截至2025一季报，公司营业总收入1.80亿元、同比增长21.85%，归属净利 润266.51万元，同比增长1 ...

Group 1 - The core viewpoint of the article highlights the performance of the Shanghai Composite Index and the Hang Seng Index on July 29, with the former rising by 0.33% to close at 3609.71 points and the latter falling by 0.15% to close at 25524.45 points [1] - Fudan Zhangjiang's A/H share premium reached 171.57%, ranking fourth among A/H shares, with A shares closing at 10.75 yuan (up 2.97%) and H shares at 4.33 HKD (up 2.61%) [1] - Shanghai Fudan Zhangjiang Biopharmaceutical Co., Ltd. was established in November 1996 in the Zhangjiang Hi-Tech Park, with notable shareholders including Shanghai Pharmaceuticals Holding Co., Ltd. [1] Group 2 - The company focuses on innovative research, development, production, and sales in the biopharmaceutical sector, aiming to become a leading innovation enterprise centered on intellectual property [1] - Over the years, the company has developed competitive advantages in areas such as gene technology drugs, photodynamic therapy drugs, nanotechnology drugs, and oral solid dosage technology drugs, with new products expected to be launched in the market [1] - The company has undertaken several national key science and technology projects, including the "National Key Technology R&D Program," "National High Technology Research and Development Program (863 Program)," and the "Major New Drug Creation" science and technology major special project [1]

Core Viewpoint - The Hong Kong pharmaceutical stocks are experiencing a strong performance, with notable gains in several companies [1] Company Performance - Sanofi Pharmaceutical-B (02257.HK) increased by 5.50% - Kangfang Biotech (09926.HK) rose by 5.23% - Genscript Biotech (01952.HK) saw a rise of 4.38% - Fudan Zhangjiang (01349.HK) grew by 4.21% [1]

Group 1 - The major shareholders of Fudan Zhangjiang Bio-Pharmaceutical Co., Ltd. are Yang Zongmeng and Wang Haibo, holding 7.18% and 5.41% of the total shares respectively before the reduction plan [1][2] - Yang Zongmeng planned to reduce his holdings by up to 4,270,800 shares, which is 0.41% of the total share capital, due to personal financial needs [1][2] - The reduction plan was disclosed on June 23, 2025, and the actual reduction took place from July 14 to July 16, 2025 [2][3] Group 2 - Yang Zongmeng reduced his holdings by 10,365,721 shares, representing 1.00% of the total share capital, with a total amount of approximately 92.79 million yuan [2][3] - Wang Haibo reduced his holdings by 4,270,722 shares, which is 0.41% of the total share capital, with a total amount of approximately 38.59 million yuan [3] - After the reductions, Yang Zongmeng's remaining shares are 64,009,773, which is 6.18% of the total share capital, while Wang Haibo's remaining shares are 51,828,605, which is 5.00% [3]

Group 1 - The Hang Seng Index fell by 0.08% on July 17, with southbound trading totaling HKD 134.72 billion, including HKD 68.29 billion in buying and HKD 66.43 billion in selling, resulting in a net inflow of HKD 1.85 billion [1] - The southbound trading through Stock Connect (Shenzhen) had a total turnover of HKD 49.60 billion, with net buying of HKD 0.19 billion, while Stock Connect (Shanghai) had a turnover of HKD 85.12 billion, with net buying of HKD 1.67 billion [1] - The most actively traded stock by southbound funds was Xiaomi Group-W, with a total turnover of HKD 64.88 billion, followed by Alibaba-W and Guotai Junan International with turnovers of HKD 52.03 billion and HKD 50.25 billion respectively [1] Group 2 - Among the stocks with net buying, Meituan-W led with a net inflow of HKD 6.06 billion, while China Construction Bank and Xiaomi Group-W followed with net inflows of HKD 5.91 billion and HKD 3.15 billion respectively [1][2] - The stock with the highest net selling was Pop Mart, with a net outflow of HKD 8.44 billion, and Tencent Holdings and Kangfang Biotech also experienced significant net selling of HKD 3.79 billion and HKD 0.76 billion respectively [1][2] - Meituan-W has seen continuous net buying for 9 days, with a total net inflow of HKD 72.14 billion during this period [2]

Core Insights - On July 17, 2025, Xiaomi Group-W (01810), Guotai Junan International (01788), and Alibaba-W (09988) were the top three companies by trading volume in the Southbound Stock Connect, with trading amounts of 3.809 billion, 3.754 billion, and 3.426 billion respectively [1] - In the Shenzhen-Hong Kong Stock Connect, Xiaomi Group-W (01810), Alibaba-W (09988), and Li Auto-W (02015) led the trading volume, with amounts of 2.680 billion, 1.777 billion, and 1.720 billion respectively [1] Southbound Stock Connect - Top Active Companies - Xiaomi Group-W (01810) had a trading amount of 3.809 billion with a net buying amount of +606 million [2] - Guotai Junan International (01788) recorded a trading amount of 3.754 billion with a net buying amount of +145 million [2] - Alibaba-W (09988) had a trading amount of 3.426 billion with a net buying amount of +30.17 million [2] - Other notable companies included Pop Mart (09992) with a trading amount of 2.162 billion and a net selling amount of -478 million, and Li Auto-W (02015) with a trading amount of 1.997 billion and a net selling amount of -204 million [2] Shenzhen-Hong Kong Stock Connect - Top Active Companies - Xiaomi Group-W (01810) had a trading amount of 2.680 billion with a net selling amount of -290 million [2] - Alibaba-W (09988) recorded a trading amount of 1.777 billion with a net buying amount of +51.36 million [2] - Li Auto-W (02015) had a trading amount of 1.720 billion with a net buying amount of +29.1 million [2] - Other significant companies included Tencent Holdings (00700) with a trading amount of 1.627 billion and a net selling amount of -379 million, and Pop Mart (09992) with a trading amount of 1.316 billion and a net selling amount of -366 million [2]